Although the authors did not evaluate the behaviour of YAP-inhibited cells, they observed that intravenous injected cells with the mutated YAP pathway resulted in a fivefold increase of the brain tumour burden in mice when compared to wild-type ones. Here, YAP1 is linked to brain neoplasm.